Cargando…
Transporter-mediated natural product–drug interactions for the treatment of cardiovascular diseases
The growing use of natural products in cardiovascular (CV) patients has been greatly raising the concerns about potential natural product–CV drug interactions. Some of these may lead to unexpected cardiovascular adverse effects and it is, therefore, essential to identify or predict potential natural...
Autor principal: | Zha, Weibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326887/ https://www.ncbi.nlm.nih.gov/pubmed/29703385 http://dx.doi.org/10.1016/j.jfda.2017.11.008 |
Ejemplares similares
-
Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
por: Klatt, Sabine, et al.
Publicado: (2011) -
Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
por: Pala, Rajasekharreddy, et al.
Publicado: (2020) -
Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
por: Li, Yang, et al.
Publicado: (2021) -
Natural Compounds Modulate Drug Transporter Mediated Oral Cancer Treatment
por: Yang, Hsiang, et al.
Publicado: (2020) -
Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions
por: Li, Jie, et al.
Publicado: (2022)